基本信息
产品编号:N10186 |
|||||
产品名称:β-d-N4-hydroxycytidine |
|||||
CAS: |
3258-02-4 |
储存条件 |
粉末 |
-20℃ |
四年 |
分子式: |
溶于液体 |
-80℃ |
两年 |
||
分子量 |
259.22 |
|
|
||
化学名: |
|||||
Solubility (25°C) |
体外 |
DMSO |
|
||
Ethanol |
3mg/mL (11.57mM) |
||||
Water |
15mg/mL (57.86mM) |
||||
体内 |
现配现用 |
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
3.8577mL |
19.2886mL |
38.5773mL |
5mM |
0.7715mL |
3.8577mL |
7.7155mL |
10mM |
0.3858mL |
1.9289mL |
3.8577mL |
50mM |
0.0772mL |
0.3858mL |
0.7715mL |
生物活性
产品描述 |
一种有效的抗委内瑞拉马脑炎病毒剂。 |
|||
靶点/IC50 |
SARS-CoV |
Enterovirus |
HCV |
Topoisomerase |
体外研究 |
Beta-d-N4-hydroxycytidine is an anti-VEEV (venezuelan equine encephalitis virus) agent with EC50, EC90, and EC99 are 0.426,1.036, and 2.5μM, respectively. Beta-d-N4-hydroxycytidine inhibits CHIKV replicon activity and the 50% effective concentration (EC50) s 0.8μM in the Huh7–CHIKV replicon cell line. Similar results is presented with the replicon in BHK-21 cells (EC50=1.8μM). NHC has no cytotoxicity for NHC in the Huh-7 cell culture system until up to 100μM using MTT assays. The 50% cytotoxic concentration (CCsub>50) values for NHC are determined to be 30.6μM, 7.7μM, and 2.5μM in peripheral blood mononuclear(PBM), Vero, and CEM cells, respectively. NHC behaves as a pyrimidine analog, NHC-mediated inhibition of the CHIKV replicon can be abrogated by the addition of exogenous nucleosides, such as pyrimidines C and U, but dA, dC, dG, dU, or T has no impact on the replicon. Pyrimidines A and G contributes to replicon inhibition both in the presence and in the absence of NHC. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )